Anti-aging market is forecasted to generate a revenue of $303.2 billion by 2025, the market is mainly driven by growing geriatric population, rise in technological advancements, growing medical tourism industry, and increasing volume of anti-aging cosmetic procedures.
The different types of products available in the anti-aging market are anti-wrinkle, hair color, UV absorbers, anti-stretch marks and other products. The demand for anti-wrinkle products is expected to observe fastest growth, witnessing a CAGR of 8.4% during the forecast period. The growth is mainly driven by the increasing adoption of different types of dermal fillers and Botox injection for the treatment of wrinkles.
On the basis of device, the anti-aging market is segmented into radiofrequency, laser, anti-cellulite, microdermabrasion and other devices. Radiofrequency devices held the largest share of, 40.5%, in the global market in 2017. These devices have been gaining popularity mainly due to the various benefits offered by these devices. Advantages of radiofrequency devices, such as skin tightening, aesthetic enhancement, cellulite reduction, and body contouring, have increased their adoption rate among consumers.
Among the various treatments, anti-aging products and devices were most commonly used for hair restoration treatments, with 27.4% share in 2017, demonstrating a CAGR of 8.6% during the forecast period. Rising prevalence of hair loss and androgenetic alopecia; and growing appearance consciousness are the major factors contributing to the largest share of this category.
During the forecast period, anti-aging market in APAC is expected to witness fastest growth, due to increasing medical tourism; growing aging population; increasing number of cosmetic procedures; and rising number of conferences and seminars to raise awareness among the consumers. According to The International Society of Aesthetic Plastic Surgery (ISAPS), Japan and India were among the top 10 countries for cosmetic procedures in 2016. With the increasing number of cosmetic procedures, the demand for anti-aging products and devices is expected to increase in the coming years.
With the growing aging population and rising appearance consciousness among the aged population, number of cosmetic surgical procedures has been continuously increasing across the world. Aged women are more concerned about their facial appearance and therefore opt for various cosmetic procedures, such as Botox, dermal fillers, chemical peels, and facelift, which in turn lead to rise in the demand of cosmetic procedures. For instance, according to the ISAPS, 8,548,597 injectables procedure, such as Botox, and dermal fillers, were performed in 2016, globally.
Major key players in the global anti-aging market are acquiring other aesthetic based manufacturers to expand their product portfolio for different type of skin conditions. For instance, in September 2018, Syneron Medical Ltd. acquired Ellipse A/S, a Danish medical device company that manufactures and markets laser based and intense pulse light (IPL) platforms for different types of medical and aesthetic skin treatments. This acquisition will help Syneron Medical Ltd. to strengthen its footprints in multi-application space and provide customers a comprehensive product portfolio.
In March 2017, Hologic Inc. acquired Cynosure Inc. for $66 per share in cash. Cynosure Inc. manufactures light-based aesthetic and medical systems. With this acquisition, Hologic Inc. aimed to enter into medical aesthetic market, which is expected to boost the growth of the company in the coming years.
Some of the other key players operating in the anti-aging market are The Procter and Gamble Company, Nu Skin Enterprises Inc., Lumenis Ltd., Home Skinovations Ltd., Allergan plc, The Estee Lauder Companies Inc., Coty Inc., L'Oreal S.A., Orlane S.A., Age Sciences Inc., and Alma Lasers GMBH.
Table of Content
Chapter 1. Research Background
- 1.1 Research Objectives
- 1.2 Market Definition
- 1.3 Research Scope
- 1.3.1 Market Segmentation by Product
- 1.3.2 Market Segmentation by Device
- 1.3.3 Market Segmentation by Treatment
- 1.3.4 Market Segmentation by Demography
- 1.3.5 Market Segmentation by Geography
- 1.3.6 Analysis Period
- 1.3.7 Market Data Reporting Unit
- 1.4 Key Stakeholders
Chapter 2. Research Methodology
- 2.1 Secondary Research
- 2.2 Primary Research
- 2.2.1 Breakdown of Primary Research Respondents
- 2.2.1.1 By region
- 2.2.1.2 By industry participant
- 2.2.1.3 By company type
- 2.3 Market Size Estimation
- 2.4 Data Triangulation
- 2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
- 4.1 Definition of Market Segments
- 4.1.1 By Product
- 4.1.1.1 Anti-wrinkle
- 4.1.1.1.1 Botox
- 4.1.1.1.2 Dermal fillers
- 4.1.1.2 Hair color
- 4.1.1.3 Ultraviolet (UV) absorbers
- 4.1.1.4 Anti-stretch marks
- 4.1.1.5 Others
- 4.1.2 By Device
- 4.1.2.1 Radiofrequency
- 4.1.2.2 Laser
- 4.1.2.3 Anti-cellulite
- 4.1.2.4 Microdermabrasion
- 4.1.2.5 Others
- 4.1.3 By Treatment
- 4.1.3.1 Hair restoration treatment
- 4.1.3.2 Anti-pigmentation
- 4.1.3.3 Anti-adult acne therapy
- 4.1.3.4 Breast augmentation
- 4.1.3.5 Liposuction
- 4.1.3.6 Chemical peel
- 4.1.3.7 Others
- 4.1.4 By Demography
- 4.1.4.1 Generation X
- 4.1.4.2 Baby boomer
- 4.1.4.3 Generation Y
- 4.2 Market Dynamics
- 4.2.1 Trends
- 4.2.1.1 Increasing inclination of consumers toward easy to use at-home anti-aging devices
- 4.2.2 Drivers
- 4.2.2.1 Increasing number of anti-aging seminars, conferences and campaigns
- 4.2.2.2 Surge in geriatric population
- 4.2.2.3 Rising disposable income
- 4.2.2.4 Technological advancements in anti-aging products and devices
- 4.2.2.5 Growing medical tourism industry
- 4.2.2.6 Increasing volume of anti-aging cosmetic procedures
- 4.2.2.7 Impact analysis of drivers on market forecast
- 4.2.3 Restraints
- 4.2.3.1 High cost of anti-aging devices and treatments
- 4.2.3.2 Stringent regulatory requirements
- 4.2.3.3 Risk and side-effects associated with the use of anti-aging devices
- 4.2.3.4 Impact analysis of restraints on market forecast
- 4.2.4 Opportunities
- 4.2.4.1 Unmet need for minimally or non-invasive treatments
- 4.2.4.2 Rising use of social networking and e-commerce platforms
- 4.3 Porter's Five Forces Analysis
- 4.3.1 Bargaining Power of Buyers
- 4.3.2 Bargaining Power of Suppliers
- 4.3.3 Intensity of Rivalry
- 4.3.4 Threat of New Entrants
- 4.3.5 Threat of Substitutes
Chapter 5. Global Market Size and Forecast
- 5.1 By Product
- 5.1.1 Anti-Wrinkle Market, by Type
- 5.2 By Device
- 5.3 By Treatment
- 5.4 By Demography
- 5.5 By Region
Chapter 6. North America Market Size and Forecast
- 6.1 By Product
- 6.1.1 Anti-Wrinkle Market, by Type
- 6.2 By Device
- 6.3 By Treatment
- 6.4 By Demography
- 6.5 By Country
- 6.5.1 U.S. Anti-Aging Market
- 6.5.1.1 By product
- 6.5.1.1.1 Anti-wrinkle market, by type
- 6.5.1.2 By device
- 6.5.1.3 By treatment
- 6.5.1.4 By demography
- 6.5.2 Canada Anti-Aging Market
- 6.5.2.1 By product
- 6.5.2.1.1 Anti-wrinkle market, by type
- 6.5.2.2 By device
- 6.5.2.3 By treatment
- 6.5.2.4 By demography
Chapter 7. Europe Market Size and Forecast
- 7.1 By Product
- 7.1.1 Anti-Wrinkle Market, by Type
- 7.2 By Device
- 7.3 By Treatment
- 7.4 By Demography
- 7.5 By Country
- 7.5.1 Germany Anti-Aging Market
- 7.5.1.1 By product
- 7.5.1.1.1 Anti-wrinkle market, by type
- 7.5.1.2 By device
- 7.5.1.3 By treatment
- 7.5.1.4 By demography
- 7.5.2 U.K. Anti-Aging Market
- 7.5.2.1 By product
- 7.5.2.1.1 Anti-wrinkle market, by type
- 7.5.2.2 By device
- 7.5.2.3 By treatment
- 7.5.2.4 By demography
- 7.5.3 France Anti-Aging Market
- 7.5.3.1 By product
- 7.5.3.1.1 Anti-wrinkle market, by type
- 7.5.3.2 By device
- 7.5.3.3 By treatment
- 7.5.3.4 By demography
- 7.5.4 Italy Anti-Aging Market
- 7.5.4.1 By product
- 7.5.4.1.1 Anti-wrinkle market, by type
- 7.5.4.2 By device
- 7.5.4.3 By treatment
- 7.5.4.4 By demography
- 7.5.5 Spain Anti-Aging Market
- 7.5.5.1 By product
- 7.5.5.1.1 Anti-wrinkle market, by type
- 7.5.5.2 By device
- 7.5.5.3 By treatment
- 7.5.5.4 By demography
Chapter 8. APAC Market Size and Forecast
- 8.1 By Product
- 8.1.1 Anti-Wrinkle Market, by Type
- 8.2 By Device
- 8.3 By Treatment
- 8.4 By Demography
- 8.5 By Country
- 8.5.1 Japan Anti-Aging Market
- 8.5.1.1 By product
- 8.5.1.1.1 Anti-wrinkle market, by type
- 8.5.1.2 By device
- 8.5.1.3 By treatment
- 8.5.1.4 By demography
- 8.5.2 China Anti-Aging Market
- 8.5.2.1 By product
- 8.5.2.1.1 Anti-wrinkle market, by type
- 8.5.2.2 By device
- 8.5.2.3 By treatment
- 8.5.2.4 By demography
- 8.5.3 India Anti-Aging Market
- 8.5.3.1 By product
- 8.5.3.1.1 Anti-wrinkle market, by type
- 8.5.3.2 By device
- 8.5.3.3 By treatment
- 8.5.3.4 By demography
- 8.5.4 South Korea Anti-Aging Market
- 8.5.4.1 By product
- 8.5.4.1.1 Anti-wrinkle market, by type
- 8.5.4.2 By device
- 8.5.4.3 By treatment
- 8.5.4.4 By demography
Chapter 9. LATAM Market Size and Forecast
- 9.1 By Product
- 9.1.1 Anti-Wrinkle Market, by Type
- 9.2 By Device
- 9.3 By Treatment
- 9.4 By Demography
- 9.5 By Country
- 9.5.1 Brazil Anti-Aging Market
- 9.5.1.1 By product
- 9.5.1.1.1 Anti-wrinkle market, by type
- 9.5.1.2 By device
- 9.5.1.3 By treatment
- 9.5.1.4 By demography
- 9.5.2 Mexico Anti-Aging Market
- 9.5.2.1 By product
- 9.5.2.1.1 Anti-wrinkle market, by type
- 9.5.2.2 By device
- 9.5.2.3 By treatment
- 9.5.2.4 By demography
Chapter 10. MEA Market Size and Forecast
- 10.1 By Product
- 10.1.1 Anti-Wrinkle Market, by Type
- 10.2 By Device
- 10.3 By Treatment
- 10.4 By Demography
- 10.5 By Country
- 10.5.1 Saudi Arabia Anti-Aging Market
- 10.5.1.1 By product
- 10.5.1.1.1 Anti-wrinkle market, by type
- 10.5.1.2 By device
- 10.5.1.3 By treatment
- 10.5.1.4 By demography
Chapter 11. Competitive Landscape
- 11.1 Product Benchmarking of Key Players
- 11.2 Global Strategic Developments of Key Players
- 11.2.1 Mergers and Acquisitions
- 11.2.2 Product Launches and Approvals
- 11.2.3 Partnerships and Collaborations
- 11.2.4 Other Developments
Chapter 12. Company Profiles
- 12.1 The Procter & Gamble Company
- 12.1.1 Business Overview
- 12.1.2 Product and Service Offerings
- 12.1.3 Key Financial Summary
- 12.2 Nu Skin Enterprises Inc.
- 12.2.1 Business Overview
- 12.2.2 Product and Service Offerings
- 12.2.3 Key Financial Summary
- 12.3 Lumenis Ltd.
- 12.3.1 Business Overview
- 12.3.2 Product and Service Offerings
- 12.4 Hologic Inc.
- 12.4.1 Business Overview
- 12.4.2 Product and Service Offerings
- 12.4.3 Key Financial Summary
- 12.5 Syneron Medical Ltd.
- 12.5.1 Business Overview
- 12.5.2 Product and Service Offerings
- 12.5.3 Key Financial Summary
- 12.6 Home Skinovations Ltd.
- 12.6.1 Business Overview
- 12.6.2 Product and Service Offerings
- 12.7 Allergan plc
- 12.7.1 Business Overview
- 12.7.2 Product and Service Offerings
- 12.7.3 Key Financial Summary
- 12.8 The Estee Lauder Companies Inc.
- 12.8.1 Business Overview
- 12.8.2 Product and Service Offerings
- 12.8.3 Key Financial Summary
- 12.9 Coty Inc.
- 12.9.1 Business Overview
- 12.9.2 Product and Service Offerings
- 12.9.3 Key Financial Summary
- 12.10 L'Oreal S.A.
- 12.10.1 Business Overview
- 12.10.2 Product and Service Offerings
- 12.10.3 Key Financial Summary
- 12.11 Orlane S.A.
- 12.11.1 Business Overview
- 12.11.2 Product and Service Offerings
- 12.12 Age Sciences Inc.
- 12.12.1 Business Overview
- 12.12.2 Product and Service Offerings
- 12.13 Alma Lasers GMBH
- 12.13.1 Business Overview
- 12.13.2 Product and Service Offerings
Chapter 13. Appendix
- 13.1 Abbreviations
- 13.2 Sources and References
- 13.3 Related Reports
